Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area ubiquitination e2 conjugating'

Search results for: 'research area ubiquitination e2 conjugating'

Items 21-30 of 208

Page
per page
  1. FK 866 hydrochloride
    A8631 FK 866 hydrochloride
    Target: NMPRTase
    Summary: NMPRTase inhibitor
      ≥18.95 mg/mL
  2. (±)-Bay K 8644
    A8632 (±)-Bay K 8644
    Summary: L-type Ca2+-channel activator
      ≥36.2 mg/mL
  3. Concanamycin A
    A8633 Concanamycin A
     1 Citation
    Target: Vacuolar-type ATPase
    Summary: V-type (vacuolar) H+-ATPase inhibitor
      soluble in DMSO
  4. Pepstatin A
    A2571 Pepstatin A
     1 Citation
    Target: Cathepsins|Renin|HIV proteases|Pepsins
    Summary: Aspartic protease inhibitor
      ≥34.3 mg/mL
  5. Rocilinostat (ACY-1215)
    A4083 Rocilinostat (ACY-1215)
     1 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: Selective HDAC6 inhibitor
      ≥21.675 mg/mL
  6. E 64d
    A1903 E 64d
     4 Citation
    Summary: Cysteine protease inhibitor
      insoluble in H2O; ≥17.12 mg/mL
  7. Paclitaxel (Taxol)
    A4393 Paclitaxel (Taxol)
     4 Citation
    Target: Microtubules/Tubulins
    Summary: Antineoplastic agent
      ≥85.6 mg/mL
  8. Doxorubicin
    A3966 Doxorubicin
     3 Citation
    Summary: Topo II inhibitor,immunosuppresive antineoplastic antibiotic
      ≥27.2 mg/mL
  9. LY 294002
    A8250 LY 294002
     16 Citation
    Target: PI3K
    Summary: Potent PI3K inhibitor
  10. Bay 11-7821 (BAY 11-7082)
    A4210 Bay 11-7821 (BAY 11-7082)
     1 Citation
    Summary: IKK/NF-κB/TNFα inhibitor
      insoluble in H2O; ≥64 mg/mL

Items 21-30 of 208

Page
per page